Madrigal Pharmaceuticals (NASDAQ:MDGL) Issues Quarterly Earnings Results, Misses Estimates By $1 32 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
HC Wainwright Lowers Madrigal Pharmaceuticals (NASDAQ:MDGL) Price Target to $390 00 tickerreport.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tickerreport.com Daily Mail and Mail on Sunday newspapers.
Madrigal Pharmaceuticals (NASDAQ:MDGL – Get Free Report) is scheduled to post its quarterly earnings results before the market opens on Tuesday, May 7th. Analysts expect Madrigal Pharmaceuticals to post earnings of ($6.06) per share for the quarter. Persons interested in registering for the company’s earnings conference call can do so using this link. Madrigal Pharmaceuticals […]
Connor Clark & Lunn Investment Management Ltd. lowered its holdings in Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Free Report) by 21.4% in the 3rd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 51,686 shares of the biopharmaceutical company’s stock after selling 14,075 shares during the […]
Madrigal Pharmaceuticals, Inc. (NASDAQ:MDGL – Get Free Report) has earned an average rating of “Moderate Buy” from the seven research firms that are presently covering the firm, Marketbeat Ratings reports. One analyst has rated the stock with a hold rating and six have issued a buy rating on the company. The average 1-year price objective […]